Open AccessCombination of Ad-SGE-REIC and bevacizumab modulates glioma progression by suppressing tumor invasion and angiogenesis
Author(s) -
Yasuhiko Hattori,
Kazuhiko Kurozumi,
Yoshihiro Otani,
Atsuhito Uneda,
Nobushige Tsuboi,
Keigo Makino,
Shuichiro Hirano,
Kentaro Fujii,
Yusuke Tomita,
Tetsuo Oka,
Yuji Matsumoto,
Yosuke Shimazu,
Hiroyuki Michiue,
Hiromi Kumon,
Isao Date
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0273242
Subject(s) - bevacizumab , glioma , cancer research , angiogenesis , medicine , vascular endothelial growth factor , genetic enhancement , chemotherapy , biology , gene , vegf receptors , biochemistry